Longitudinal Imaging Biomarkers of Disease Progression in DLB
NCT03582488
·
clinicaltrials.gov ↗
PHASE4
Phase
ENROLLING_BY_INVITATION
Status
135
Enrollment
OTHER
Sponsor class
Conditions
Lewy Body Disease
Interventions
DRUG:
18F-Flortaucipir
Sponsor
Kejal Kantarci
Collaborators
[object Object]